This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (72)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Potential Mechanisms and Clinical Implications

Aram V. Chobanian, MD; R. Wayne Alexander, MD

Arch Intern Med. 1996;156(17):1952-1956.

Abstract
Recent experimental data suggest marked similarities between the effects of hypertension and hypercholesterolemia on the arterial intima. Both conditions also seem to exert proinflammatory effects on the artery, resulting in the recruitment of monocytes into the intima. These effects may be due to production of oxygen-free radicals, which in turn may stimulate genes involved in the recruitment of inflammatory cells into the arterial wall. Plaque rupture and acute myocardial infarction are related to local accumulation of inflammatory cells in vulnerable areas of the plaque. Recent clinical trials using cholesterol-lowering or antihypertensive therapies have shown a decrease in cardiovascular events that may have resulted from withdrawal of inflammatory effects on the arterial wall. Angiotensin-converting enzyme inhibitors decrease the rate of myocardial infarction in patients with overt congestive heart failure or left ventricular dysfunction. These drugs probably affect several mechanisms related to the inhibition of angiotensin production and the potentiation of bradykinin and resultant enhancement of nitric oxide and prostacyclin. The mechanisms could include reversing the proinflammatory effects of angiotensin and hypercholesterolemia on the arterial wall. Future therapeutic strategies of vascular protection in hypertension may include direct attacks on proinflammatory or pro-oxidant vascular mechanisms.

Arch Intern Med. 1996;156:1952-1956

Author Affiliations
From the Boston (Mass) University School of Medicine (Dr Chobanian), and the Emory University School of Medicine, Atlanta, Ga (Dr Alexander).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells
Ramkhelawon et al.
Circ. Res. 2009;105:869-875.
ABSTRACT | FULL TEXT  

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT  

Elevated Blood Pressure in Adolescent Boys Predicts Endothelial Dysfunction: The Cardiovascular Risk in Young Finns Study
Juonala et al.
Hypertension 2006;48:424-430.
ABSTRACT | FULL TEXT  

Redox signalling in vascular responses to shear and stretch
Lehoux
Cardiovasc Res 2006;71:269-279.
ABSTRACT | FULL TEXT  

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui and Mallat
Physiol. Rev. 2006;86:515-581.
ABSTRACT | FULL TEXT  

A Prospective Study of Plasma Lipid Levels and Hypertension in Women
Sesso et al.
Arch Intern Med 2005;165:2420-2427.
ABSTRACT | FULL TEXT  

Segment-Specific Effects of Cardiovascular Risk Factors on Carotid Artery Intima-Medial Thickness in Women at Midlife
Schott et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1951-1956.
ABSTRACT | FULL TEXT  

Hypertension: A Novel Regulator of Adaptive Immunity in Atherosclerosis?
Tedgui and Mallat
Hypertension 2004;44:257-258.
FULL TEXT  

Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events
Blake et al.
Circulation 2003;108:2993-2999.
ABSTRACT | FULL TEXT  

Association Between Blood Pressure and C-Reactive Protein Levels in Acute Ischemic Stroke
Di Napoli and Papa
Hypertension 2003;42:1117-1123.
ABSTRACT | FULL TEXT  

Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The Bogalusa Heart Study
Li et al.
JAMA 2003;290:2271-2276.
ABSTRACT | FULL TEXT  

Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade
Schiffrin and Touyz
J Am Coll Cardiol 2003;42:911-913.
FULL TEXT  

Increased Atherosclerosis and Smooth Muscle Cell Hypertrophy in Natriuretic Peptide Receptor A-/-Apolipoprotein E-/- Mice
Alexander et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1077-1082.
ABSTRACT | FULL TEXT  

Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension
Rathaus and Bernheim
Nephrol Dial Transplant 2002;17:216-221.
ABSTRACT | FULL TEXT  

Blood Pressure and Inflammation in Apparently Healthy Men
Chae et al.
Hypertension 2001;38:399-403.
ABSTRACT | FULL TEXT  

Effect of Antihypertensive Therapy on Renal Artery Structure in Type 2 Diabetic Rats With Hypertension
Reddi et al.
Hypertension 2001;37:1273-1278.
ABSTRACT | FULL TEXT  

Genetic Modifiers of Atherosclerosis in Mice
Knowles and Maeda
Arterioscler. Thromb. Vasc. Bio. 2000;20:2336-2345.
ABSTRACT | FULL TEXT  

Positional Genomic Analysis Identifies the {beta}2-Adrenergic Receptor Gene as a Susceptibility Locus for Human Hypertension
Bray et al.
Circulation 2000;101:2877-2882.
ABSTRACT | FULL TEXT  

Blood Pressure and the Progression of Carotid Atherosclerosis in Middle-Aged Men
Lakka et al.
Hypertension 1999;34:51-56.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension
Pierdomenico et al.
Hypertension 1998;31:621-626.
ABSTRACT | FULL TEXT  

Exacerbation of Atherosclerosis by Hypertension: Potential Mechanisms and Clinical Implications
Lip
Arch Intern Med 1997;157:1265-1266.
ABSTRACT  

Primary Hypertension: From Pathophysiology to Prevention
Kaplan
Arch Intern Med 1996;156:1919-1920.
ABSTRACT